XGN logo

Exagen Inc. (XGN)

Profile

Full Name

Exagen Inc.

Ticker

NASDAQ: XGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

September 19, 2019

Indexes

Not included

Website

https://www.exagen.com

Employees

209

Key Details

Price

$6.13(-0.97%)

Market Cap

$138.92M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$55.64M(5.89% YoY)

Annual EPS

-$0.83(38.03% YoY)

PE Ratio

-

Next earnings date

Mar 10, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $6.13
    XGN price is $6.13

    30-Day Relative Volume

    0.73
    XGN 30-day relative volume is 0.73

    Price Performance

    Price Most Recent Change

    -0.97%
    XGN price was down -0.97% on Dec 26, 2025

    Price YTD Change

    +49.51%
    XGN price is up +49.51% since January 1st

    Price 1-Year Change

    +21.63%
    XGN price is up +21.63% year-on-year

    Price 3-Year Change

    +150.2%
    XGN price is up +150.2% over the past 3 years

    Price Range

    Price All-Time High

    $29.86
    XGN price is currently -79.47% below its historical high of $29.86

    Price 3-Year Low

    $1.30
    XGN price is currently +371.54% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $138.92M
    XGN market cap is $138.92 million

    Market Cap 3-Year Change

    +247.46%
    XGN market cap is up +247.46% over the past 3 years

    Market Cap All-Time High

    $357.74M
    XGN market cap is currently -61.17% below its historical high of $357.74 million

    Market Cap Sector Percentile

    44.35%
    XGN market cap is higher than 44.35% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +28.5%
    XGN shares outstanding is up +28.5% year-on-year

    Shares Outstanding 3-Year Change

    +38.87%
    XGN shares outstanding is up +38.87% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.37
    XGN beta is 1.37

    200-day SMA

    $7.79
    XGN price is currently -21.28% below its 200-day simple moving average

    50-day SMA

    $8.84
    XGN price is currently -30.69% below its 50-day simple moving average

    14-Day RSI

    24.64
    XGN 14-day relative strength index is 24.64

    Volume

    0.73
    XGN 30-day relative volume is 0.73

    ATR

    $0.39
    XGN average true range is $0.39

    10-day Historical Volatility

    40.11%
    XGN 10-day historical volatility is 40.11%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $55.64M
    XGN annual revenue is $55.64 million

    Revenue Analysts Estimate

    $67.08M
    XGN annual revenue is currently -17.05% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +5.89%
    XGN annual revenue is up +5.89% year-on-year

    Revenue Sector Percentile

    62.4%
    XGN annual revenue is higher than 62.4% of companies in Healthcare sector

    EPS

    EPS

    -$0.83
    XGN annual earnings per share is -$0.83

    EPS Analysts Estimate

    -$0.84
    XGN annual earnings per share is currently +1.14% higher than the consensus analysts' forecast

    EPS 1-Year Change

    +38.03%
    XGN annual earnings per share is up +38.03% year-on-year

    EPS Sector Percentile

    60%
    XGN annual earnings per share is higher than 60% of companies in Healthcare sector

    Profit

    Gross Profit

    $33.11M
    XGN annual gross profit is $33.11 million

    Gross Margin

    59.51%
    XGN annual gross profit margin is 59.51%

    Operating Profit

    -$13.64M
    XGN annual operating income is -$13.64 million

    Operating Margin

    -24.51%
    XGN annual operating profit margin is -24.51%

    Net Income

    -$15.12M
    XGN annual net profit is -$15.12 million

    Net Margin

    -27.17%
    XGN annual net profit margin is -27.17%

    Expenses

    Total Expenses

    $69.28M
    XGN annual total expenses is $69.28 million

    Operating Expenses

    $46.75M
    XGN annual total operating expenses is $46.75 million

    Cost Of Goods Sold

    $22.53M
    XGN annual cost of goods sold is $22.53 million

    Selling, General & Administrative Expenses

    $41.37M
    XGN annual SG&A is $41.37 million

    Depreciation & Amortization

    $1.72M
    XGN annual D&A is $1.72 million

    Interest Expense

    $2.23M
    XGN annual interest expense is $2.23 million

    Income Tax

    $12.00K
    XGN annual income tax is $12.00 thousand

    EBIT & EBITDA

    EBIT

    -$12.87M
    XGN annual earnings before interest & taxes is -$12.87 million

    EBITDA

    -$11.14M
    XGN annual EBITDA is -$11.14 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $45.40M
    XGN annual total assets is $45.40 million

    Non Current Assets

    $8.23M
    XGN annual long term assets is $8.23 million

    Current Assets

    $36.45M
    XGN annual total current assets is $36.45 million

    Cash and Cash Equivalents

    $22.04M
    XGN annual cash & cash equivalents is $22.04 million

    Accounts Receivable

    $7.83M
    XGN annual accounts receivable is $7.83 million

    Inventory

    $5.72M
    XGN annual inventory is $5.72 million

    Liabilities

    Total Liabilities

    $35.86M
    XGN annual total liabilities is $35.86 million

    Long Term Liabilities

    $21.64M
    XGN annual total long term liabilities is $21.64 million

    Current Liabilities

    $13.51M
    XGN annual current liabilities is $13.51 million

    Accounts Payable

    $4.14M
    XGN annual accounts payable is $4.14 million

    Debt

    Total Debt

    $23.36M
    XGN annual total debt is $23.36 million

    Total Debt 1-Year Change

    -1.51%
    XGN annual total debt is down -1.51% year-on-year

    Long Term Debt

    $21.64M
    XGN annual long term debt is $21.64 million

    Short Term Debt

    $1.52M
    XGN annual short term debt is $1.52 million

    Equity & Capital

    Shareholders Equity

    $9.54M
    XGN annual stockholders equity is $9.54 million

    Book Value

    $9.54M
    XGN annual book value is $9.54 million

    Retained Earnings

    -$294.33M
    XGN annual retained earnings is -$294.33 million

    Working Capital

    $22.95M
    XGN annual working capital is $22.95 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$13.28M
    XGN annual cash from operations is -$13.28 million

    Cash From Operations 1-Year Change

    +8.18%
    XGN annual cash from operations is up +8.18% year-on-year

    Cash From Investing

    -$515.00K
    XGN annual cash from investing is -$515.00 thousand

    Cash From Investing 1-Year Change

    +35.95%
    XGN annual cash from investing is up +35.95% year-on-year

    Cash From Financing

    -$663.00K
    XGN annual cash from financing is -$663.00 thousand

    Cash From Financing 1-Year Change

    +93.76%
    XGN annual cash from financing is up +93.76% year-on-year

    CAPEX

    CAPEX

    $515.00K
    XGN annual capital expenditures is $515.00 thousand

    CAPEX 1-Year Change

    -37.8%
    XGN annual capital expenditures is down -37.8% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$13.79M
    XGN annual free cash flow is -$13.79 million

    Free Cash Flow 1-Year Change

    +9.78%
    XGN annual free cash flow is up +9.78% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    59.51%
    XGN annual gross profit margin is 59.51%

    Operating Margin

    -24.51%
    XGN annual operating profit margin is -24.51%

    Net Margin

    -27.17%
    XGN annual net profit margin is -27.17%

    ROA & ROE

    ROA

    -29.54%
    XGN annual return on assets is -29.54%

    ROE

    -93.78%
    XGN annual return on equity is -93.78%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    XGN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    XGN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    7.66
    XGN price to book ratio is 7.66

    PB Ratio Sector Percentile

    83.88%
    XGN price to book ratio is higher than 83.88% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    2.18
    XGN price to sales ratio is 2.18

    PS Ratio Sector Percentile

    37.61%
    XGN price to sales ratio is higher than 37.61% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $131.44M
    XGN enterprise value is $131.44 million

    Enterprise Value Sector Percentile

    46.5%
    XGN enterprise value is higher than 46.5% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -12.46
    XGN EV/EBITDA is -12.46

    EV/EBITDA Sector Percentile

    12.33%
    XGN EV/EBITDA is higher than 12.33% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.70
    XGN annual current ratio is 2.70

    Quick Ratio

    2.28
    XGN annual quick ratio is 2.28

    Leverage

    Debt To Equity

    2.12
    XGN annual debt to equity ratio is 2.12

    Interest Coverage Ratio

    -5.76
    XGN annual interest coverage ratio is -5.76

    Risk & Stability

    F-Score

    4
    XGN piotroski f-score is 4

    Altman Z-Score

    -5.86
    XGN altman z-score is -5.86

    Analyst ratings

    Recent major analysts updates

    Nov 10, 25 BTIG
    Buy
    Nov 5, 25 B. Riley Securities
    Buy
    Oct 27, 25 Canaccord Genuity
    Buy
    Oct 22, 25 BTIG
    Buy
    Oct 14, 25 Keybanc
    Overweight
    Sep 11, 25 B. Riley Securities
    Buy
    Jul 30, 25 Keybanc
    Overweight
    Jul 30, 25 Canaccord Genuity
    Buy
    Jul 23, 25 Craig-Hallum
    Buy
    May 15, 25 Cantor Fitzgerald
    Overweight

    Institutional Ownership

    Screeners with XGN included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Exagen Inc.?
    • Does Exagen Inc. pay dividends?
    • What sector is Exagen Inc. in?
    • What industry is Exagen Inc. in?
    • What country is Exagen Inc. based in?
    • When did Exagen Inc. go public?
    • Is Exagen Inc. in the S&P 500?
    • Is Exagen Inc. in the NASDAQ 100?
    • Is Exagen Inc. in the Dow Jones?
    • When was Exagen Inc.'s last earnings report?
    • When does Exagen Inc. report earnings?

    What is the ticker symbol for Exagen Inc.?

    The ticker symbol for Exagen Inc. is NASDAQ:XGN

    Does Exagen Inc. pay dividends?

    No, Exagen Inc. does not pay dividends

    What sector is Exagen Inc. in?

    Exagen Inc. is in the Healthcare sector

    What industry is Exagen Inc. in?

    Exagen Inc. is in the Diagnostics & Research industry

    What country is Exagen Inc. based in?

    Exagen Inc. is headquartered in United States

    When did Exagen Inc. go public?

    Exagen Inc.'s initial public offering (IPO) was on September 19, 2019

    Is Exagen Inc. in the S&P 500?

    No, Exagen Inc. is not included in the S&P 500 index

    Is Exagen Inc. in the NASDAQ 100?

    No, Exagen Inc. is not included in the NASDAQ 100 index

    Is Exagen Inc. in the Dow Jones?

    No, Exagen Inc. is not included in the Dow Jones index

    When was Exagen Inc.'s last earnings report?

    Exagen Inc.'s most recent earnings report was on November 4, 2025

    When does Exagen Inc. report earnings?

    The next expected earnings date for Exagen Inc. is March 10, 2026
    On this page